Get the Stockscreener App
0.281
5.16%
0.0138
After Hours:
.28
-0.001
-0.36%
Accuray Inc stock is traded at $0.281, with a volume of 4.59M.
It is up +5.16% in the last 24 hours and up +8.08% over the past month.
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.
See More
Previous Close:
$0.2672
Open:
$0.2627
24h Volume:
4.59M
Relative Volume:
0.67
Market Cap:
$33.56M
Revenue:
$436.97M
Net Income/Loss:
$-35.62M
P/E Ratio:
-0.942
EPS:
-0.2983
Net Cash Flow:
$-10.71M
1W Performance:
+30.64%
1M Performance:
+8.08%
6M Performance:
-32.34%
1Y Performance:
-82.97%
1-Day Range:
$0.2574
$0.3049
1-Week Range:
$0.2454
$0.382
52-Week Range:
$0.2151
$2.10
Accuray Inc Stock (ARAY) Company Profile
Name
Accuray Inc
Sector
Industry
Phone
608-824-2800
Address
1240 DEMING WAY, MADISON, CA
Compare ARAY vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ARAY
Accuray Inc
|
0.281 | 25.69M | 436.97M | -35.62M | -10.71M | -0.2983 |
ABT
Abbott Laboratories
|
97.50 | 175.27B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
86.38 | 113.38B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
275.43 | 104.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
42.60 | 63.65B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.15 | 49.74B | 6.30B | 1.07B | 1.09B | 1.8406 |
Accuray Inc Stock (ARAY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-13-24 | Initiated | ROTH MKM | Buy |
| Jun-23-22 | Initiated | B. Riley Securities | Buy |
| Dec-22-21 | Initiated | Loop Capital | Buy |
| Jan-21-20 | Upgrade | BTIG Research | Neutral → Buy |
| Nov-01-18 | Upgrade | Citigroup | Sell → Neutral |
| Dec-13-17 | Downgrade | JP Morgan | Neutral → Underweight |
| Nov-30-17 | Initiated | Lake Street | Buy |
| Dec-14-16 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-22-15 | Initiated | RBC Capital Mkts | Sector Perform |
| Nov-12-15 | Initiated | Citigroup | Sell |
| May-01-15 | Reiterated | Dougherty & Company | Buy |
| Jan-12-15 | Initiated | Northland Capital | Outperform |
| Jan-31-14 | Reiterated | Dougherty & Company | Buy |
| Jan-29-14 | Reiterated | Brean Capital | Buy |
| Nov-11-13 | Reiterated | Dougherty & Company | Buy |
| Aug-29-13 | Reiterated | Dougherty & Company | Buy |
| Sep-20-11 | Reiterated | Ticonderoga | Buy |
| Feb-08-10 | Upgrade | Jefferies & Co | Hold → Buy |
| Dec-09-09 | Upgrade | UBS | Sell → Neutral |
| Mar-09-09 | Downgrade | Soleil | Buy → Hold |
| Jan-30-09 | Upgrade | Piper Jaffray | Neutral → Buy |
| Dec-22-08 | Reiterated | Jefferies & Co | Hold |
| Aug-20-08 | Reiterated | Jefferies & Co | Hold |
View All
Accuray Inc Stock (ARAY) Latest News
Japan Approves Accuray’s Cyberknife M6 System for Radiation Therapy Patients - Medical Product Outsourcing
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Accuray shares jump as Samsung NeuroLogica collaboration update sparks rally - Quiver Quantitative
Accuray Incorporated Stock Analysis: Bearish Trends and Key Levels Near Term - The Cryptonomist
Why Is Accuray Stock Gaining Monday? - Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Accuray (ARAY) Partners with Samsung HME America to Advance Cybe - GuruFocus
Accuray Incorporated (ARAY) Partners With Samsung NeuroLogica on Volumetric Imaging for CyberKnife - TradingView
Accuray Stock Price Forecast. Should You Buy ARAY? - StockInvest.us
Accuray, RaySearch to Collaborate on Online Adaptive Radiation Therapy - Imaging Technology News
Accuray Incorporated (ARAY) options chain - Yahoo Finance UK
Accuray Incorporated(NasdaqCM: ARAY) dropped from S&P Global BMI Index - marketscreener.com
What Accuray’s (ARAY) $8 Million RaySearch Deal Means for Its Adaptive Therapy Push - Yahoo Finance
Accuray Inc. (NASDAQ: ARAY) Announces Resale of 6.83M Shares Linked to Warrants Priced at $1.50, $1.25, and $0.01 - Kalkine Media
ACCURAY INC SEC Filing (Sep 14, 2026) - stocktitan.net
Accuray and RaySearch Agree to Collaboration Integrating RayStation Software with Accuray Platforms to Accelerate Accuray's Online Adaptive Capabilities - Investing News Network
Accuray, RaySearch to Collaborate on Adaptive Radiation Therapy - Bitget
Accuray And Raysearch Agree To Collaboration Integrating Raystation Software - TradingView
Accuray and RaySearch agree to collaboration integrating RayStation software with Accuray platforms to accelerate Accuray’s online adaptive capabilities - TradingView
ARAY Q2 2026 Earnings: EPS Swings to Profit With 103.92% Surprise, Yet Shares Fall 4.58%Retail Earnings Report - dars.gov.et
Accuray (NASDAQ: ARAY) clears 6.8M shares for investors to resell - Stock Titan
TCW GROUP INC Adds to Accuray Inc (ARAY) Stake -- Shares Trade 7 - GuruFocus
Accuray Inc (ARAY) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Accuray swaps $40M debt for equity, raises $15M cash from TCW - scanx.trade
Accuray Inc (NASDAQ: ARAY) Discloses 18.7% Beneficial Ownership by TCW Including Warrants - Kalkine Media
Accuray | 4: Statement of changes in beneficial ownership of securities-10% Owner TCW GROUP INC - Moomoo
[SCHEDULE 13D/A] ACCURAY INC Amended Major Shareholder Report - Stock Titan
Balance Sheet Rescue Meets China Drag in Accuray’s (ARAY) Mixed Quarter - Yahoo Finance
Accuray Inc FY 2026: Revenue $401.95M, EPS ($0.4) — 10-K Summary - TradingView
Accuray (ARAY) sends definitive proxy to shareholders - Stock Titan
Penny-priced Accuray (NASDAQ: ARAY) warrants set up lender share resales - Stock Titan
Accuray Inc - TradingKey
Accuray Fiscal Q4 Swings to Loss, Revenue Falls - Moomoo
ARAY|Accuray Inc|Price:0.295|Chg%:-0.020 - TradingKey
Accuray Inc (ARAY) (Q4 2026) Earnings Call Highlights: Strategic - GuruFocus
ARAY Looks 77.3% Undervalued on GF Value™ Despite Financial Chal - GuruFocus
Accuray Incorporated Q4 2026 Earnings Call Summary - Yahoo Finance
Accuray earnings beat, revenue fell short of estimates By Investing.com - Investing.com Canada
Accuray Incorporated Q4 Operating Expenses US - Moomoo
Aug 19 (Reuters)Accuray Incorporated Q4 Ne - Moomoo
Accuray (ARAY) Telefonkonferenz zu den Ergebnissen des 4. Quartals des Geschäftsjahres 2026: Servicewachstum, Rückgang der Produktumsätze - TradingKey
Earnings call transcript: Accuray posts mixed Q4 2026 results as revenue slips - Investing.com Canada
Accuray Q4 2026 Earnings Call: Complete Transcript - Benzinga
Accuray Incorporated reports results for the quarter ended June 30Earnings Summary - TradingView
Is Accuray Inc (ARAY) a Value Trap After Q4 Earnings Miss? EPS - GuruFocus
Accuray Reports Fourth Quarter and Fiscal 2026 Financial Results - investingnews.com
Accuray Q4 Results: EPS beats estimate, sales miss by 4.16% - scanx.trade
ARAY Looks 78.0% Undervalued on GF Value™ but Faces Profitabilit - GuruFocus
ARAY Looks 78.0% Undervalued on GF Value™ - GuruFocus
Accuray: Fiscal Q4 Earnings Snapshot - marketscreener.com
Accuray posts narrower-than-feared Q4 loss as cost cuts exceed targets - Investing.com Canada
Accuray Inc Stock (ARAY) Financials Data
Revenue
Net Income
Cash Flow
EPS
Accuray Inc Stock (ARAY) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Peralta Leonel | SVP, Chief Operations Officer |
Feb 28 '26 |
Option Exercise |
0.00 |
83,723 |
0 |
83,723 |
| MAYER STEVEN F | Director |
Feb 20 '26 |
Buy |
0.56 |
54,875 |
30,878 |
1,545,620 |
| MAYER STEVEN F | Director |
Feb 18 '26 |
Buy |
0.53 |
126,125 |
67,199 |
1,421,745 |
| MAYER STEVEN F | Director |
Feb 19 '26 |
Buy |
0.53 |
69,000 |
36,598 |
1,490,745 |
| Scott Byron C | Director |
Dec 31 '25 |
Option Exercise |
0.00 |
9,433 |
0 |
162,727 |
0.26%
0.38%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):